IAH0968

BIOLOGICAL2 trials

Sponsors

SUNHO（China）BioPharmaceutical CO., Ltd.

Conditions

Advanced Solid TumorSolid TumorStomach Neoplasms

Phase 1

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

SUNHO（China）BioPharmaceutical CO., Ltd.Advanced Solid Tumor

Start: 2021-07-06End: 2025-03-31Target: 97Updated: 2024-02-20

Phase 2

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer

RecruitingNCT06504732

SUNHO（China）BioPharmaceutical CO., Ltd.Solid Tumor, Stomach Neoplasms

Start: 2024-08-15End: 2029-07-01Target: 574Updated: 2026-06-05

Related Papers

A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study

Frontiers in Immunology2024-11-292 citations

A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive, heavily pretreated solid tumors: Results from a phase Ⅰa/Ⅰb, first-in-human, open-label, single-center study.

Journal of Clinical Oncology2023-06-015 citations